MICROINVASIVE VITRECTOMY 25-GAUGE IN THE TREATMENT OF PATIENTS WITH TRACTIONAL DIABETIC RETINAL DETACHMENT
Retrospective analysis of outpatient invasive surgical treatment of 56 patients (70 eyes) with total and subtotal tractional diabetic retinal detachment, treated in the period from January 2014 to December 2016. The average age of patients was 53±5.5 years; observation periods of at least 6 months. For tamponade of vitreous cavity at the conclusion of surgery used gas perftoran C3F8 (Arcad, France) and silicone oil Siluron 2000 (Fluoron GmbH, Germany). Endolaser coagulation of retina is performed on the device PUREPOINT (Alcon). Analyzed operational and postoperative complications. Studied the functional and anatomic results of treatment: the average best-corrected visual acuity improved from 0.01±0,12 to 0,21±0,14 (p<0,05). The high anatomical results (95.7 percent fit of the retina) and improve visual acuity with microinvasive technologies 25 caliber in patients with diabetic tractional detachment of the retina showed the safety and efficacy of this technology, despite the initial severity of diabetic lesions.